Lisinopril
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents
1977 • 1,851 citations
A new class of angiotensin-converting enzyme inhibitors
1980 • 704 citations
Enalapril maleate and a lysine analogue (MK‐521): disposition in man.
1982 • 213 citations
Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
1982 • 109 citations
Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography.
1985 • 108 citations
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
1985 • 93 citations
Synthesis of N2-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline (Lisinopril)
1985 • 28 citations
Enalapril in Experimental Hypertension and Acute Heart Failure
1986 • 7 citations
Angiotensin-converting enzyme: immunologic, structural, and developmental aspects.
1983 • 5 citations
Structure-activity studies with angiotensin converting enzyme inhibitors related to enalapril and MK-521.
1984 • 2 citations